Skip to content

Oxycodone vs. sufentanil in patient controlled intravenous analgesia after gynecological tumors operation: a randomized double-blind clinical trial

Oxycodone vs. sufentanil in patient controlled intravenous analgesia after gynecological tumors operation: a randomized double-blind clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014793
Enrollment
Unknown
Registered
2018-02-05
Start date
2018-02-08
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute postoperative pain

Interventions

sufentanil+sufentanil group:sufentanil iv. injection+sufentanil PCIA
oxycodone+oxycodone group:oxycodone iv. injection+oxycodone bolus only PCIA
sufentanil+oxycodone group:sufentanil iv. injection+oxycodone bolus only PCIA
oxycodone+sufentanil group:oxycodone iv. injection+sufentanil PCIA

Sponsors

Shaanxi province tumor hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults patients undergoing selective gynecological tumors surgery were included. Patients aged 18-6 year-old, BMI 18-29.5, ASA I-III

Exclusion criteria

Exclusion criteria: Patients with cardiac, pulmonary, hepatic or renal insufficiency, drug history including opioid analgesics, NSAIDs, sedative and antidepressant more than 1 month, alcohol abuse history, having mental diseases, sever hypertention ( systolic pressure>180mmHg, diastolic pressure>110mmHg), esophageal reflux disease, having sedative, antiemetic or anti-Itch drugs 24 hours before operation, pregnancy or lactation,and those unable to comprehend verbal instruction were removed from this clinical trial.

Design outcomes

Primary

MeasureTime frame
PCIA times in wards;analgesic does consumption;length of first first patient control intravenous analgesia since returning to wards ;extubation time;NRS scores;Analgesic satisfaction;Pain type;

Secondary

MeasureTime frame
FAS scores;rescues analgesia rate in PACU;First exhaust time;First feeding time;First activity time;

Countries

China

Contacts

Public ContactLichun Han

Shaanxi province tumor hospital

hanlichun696@163.com+86 13609266499

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026